News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
87 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24953)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (3)
2 (126)
3 (109)
4 (46)
5 (53)
6 (70)
7 (2)
8 (3)
9 (93)
10 (97)
11 (67)
12 (115)
13 (23)
16 (45)
17 (61)
18 (207)
19 (143)
20 (33)
21 (1)
22 (1)
23 (48)
24 (107)
25 (87)
26 (242)
27 (149)
29 (6)
30 (263)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
16
17
18
19
20
21
22
23
24
25
26
27
29
30
Genetown
Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work
Lead investor Venrock joined by Andera, Cormorant, HBM Healthcare Investments, Fresenius Medical Care Ventures GmbH, Sofinnova Partners, Apple Tree Partners and MedImmune
April 25, 2018
·
3 min read
Drug Development
Ra Pharmaceuticals Announces Presentation of RA101495 SC Phase 2 gMG Clinical Trial Design at the 70th Annual AAN Meeting
Ra Pharmaceuticals, Inc. announced that the design of its Phase 2 clinical trial of RA101495 SC as a treatment for generalized myasthenia gravis (gMG) will be presented in an oral platform presentation at the 70th Annual American Academy of Neurology (AAN), taking place April 21-27, 2018 in Los Angeles.
April 25, 2018
·
4 min read
Business
LabCorp Announces Strong 2018 First Quarter Results and Updates 2018 Guidance
LabCorp® announced results for the first quarter ended March 31, 2018, and updated 2018 guidance.
April 25, 2018
·
26 min read
Biotech Beach
PreludeDx Announces DCISionRT™ PREDICT Registry Study
Prelude Corporation announced today the official launch of its large registry study, DCISionRT PREDICT.
April 25, 2018
·
3 min read
Pharm Country
Mylan Adds to Growing Women’s Healthcare Portfolio with Launch of Generic for Oral Contraceptive Yaz®
Mylan Pharmaceuticals received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product.
April 25, 2018
·
2 min read
Business
Outcome Health Announces Partnership with Unity Consortium to Raise Awareness For and Take Action On Vaccination
Outcome Health announced a partnership with Unity Consortium, a broad base of leading public and private organizations focused on improving health through preventive healthcare and vaccination for teens and young adults.
April 25, 2018
·
3 min read
Business
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Dermtreat has appointed Nishan de Silva, M.D., as chief executive officer.
April 25, 2018
·
5 min read
Bio NC
Pattern Health Simplifies Improving Patient Adherence
Pattern Health is announcing the 2.0 release of the Pattern Platform.
April 25, 2018
·
3 min read
Business
Henry Schein To Present At Four Investor Conferences In May
Henry Schein, Inc. announced today that the Company will present at four investor conferences in May:
April 25, 2018
·
2 min read
Drug Development
Kamedis Conducts 1st U.S. Clinical Study on Chinese Botanical Efficacy for Chronic Skin Disorders
Will Evaluate Role of Patented Botanical Formulation in Kamedis OTC Eczema Solution
April 25, 2018
·
2 min read
Previous
7 of 9
Next